Update on Import and Circulation of Foreign Medicines after 1 July 2024

We are happy to announce that one of the issues relating to introduction of mandatory marking of medicines by the identification means in Kazakhstan has been solved.

Specifically, an important issueintroducing amendmentsList of Goods Subject to Marking.

Since 1 July 2024, subject to mandatory marking by the identification means are the medicines manufactured starting from 1 July 2024, packed in the dosage forms (including medicines in the form of transdermal systems) or in the form or packages for retail sale, except for the medicines and vaccines applied in veterinary practice (EAEU CN of FEA codes are specified in the List).

Thus, medicines manufactured BEFORE 1 July 2024 both in Kazakhstan and abroad may be imported into Kazakhstan after this date and further circulate on the Kazakhstan market without applying special marking by the identification means. Such medicines are not subject to mandatory marking by the identification means in Kazakhstan.

"Import and circulation of foreign "remnants" of medicines after 1 July 2024" (4 March 2024).